Biomea Fusion Inc.

12/16/2024 | Press release | Distributed by Public on 12/16/2024 17:15

Biomea Fusion to Host Conference Call to Announce Topline Results from Phase II COVALENT-111 Study in Patients with Type 2 Diabetes (T2D)